SCHEMBL7419600

SCHEMBL7419600

COC(=O)c1ccc(CCBr)nc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.56
KDM4E B2RXH2 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
MAPT P10636 4/20 0.46
ALDH1A1 P00352 1/20 0.44
RAB9A P51151 3/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
KMT2A Q03164 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
CA12 O43570 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42
NPC1 O15118 1/20 0.42
CYP4A11 Q02928 2/20 0.41
LOXL2 Q9Y4K0 1/20 0.41
CYP4F2 P78329 1/20 0.41
MEN1 O00255 1/20 0.40
CCR6 P51684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL480126 0.87 MAPK1 (0.59) MAPK1KDM4EL3MBTL1MAPTALDH1A1
SCHEMBL26030510 0.85 MAPK1 (0.57) MAPK1KDM4EL3MBTL1MAPTALDH1A1
SCHEMBL22120004 0.85 MAPK1 (0.57) MAPK1KDM4EL3MBTL1MAPTALDH1A1
SCHEMBL15878323 0.85 MAPK1 (0.57) MAPK1KDM4EL3MBTL1MAPTALDH1A1
Ammonia Solution, Strong SCHEMBL9446830 0.84 MAPK1 (0.56) MAPK1KDM4EL3MBTL1MAPTALDH1A1
SCHEMBL6205940 0.84 MAPK1 (0.56) MAPK1KDM4EL3MBTL1MAPTALDH1A1
SCHEMBL20503310 0.83 MAPK1 (0.54) MAPK1KDM4EL3MBTL1MAPTALDH1A1
SCHEMBL19876837 0.82 MAPK1 (0.57) MAPK1KDM4EL3MBTL1MAPTALDH1A1
SCHEMBL1441132 0.81 MAPK1 (0.61) MAPK1KDM4EL3MBTL1MAPTALDH1A1
SCHEMBL29695095 0.81 MAPK1 (0.61) MAPK1KDM4EL3MBTL1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3331864-A2 1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Chong Kun Dang Pharmaceutical Corp. (KR) 2018-06-13 EP disclosed
CN-105358550-A Novel histone deacetylase inhibitors KARUS THERAPEUTICS LTD 2016-02-24 CN disclosed
CN-102348682-B 1,1,1-trifluoro-2-hydroxypropyl compounds HOFFMANN LA ROCHE 2014-07-30 CN disclosed
CN-102348682-A 1,1,1-trifluoro-2-hydroxypropyl compounds HOFFMANN LA ROCHE 2012-02-08 CN disclosed
CN-101448791-B Fxr agonists LILLY CO ELI 2011-11-16 CN disclosed
CN-101448791-A FXR agonists LILLY CO ELI (US) 2009-06-03 CN disclosed
CN-1575283-A Piperazine derivatives having CCR1 receptor antagonist activity PFIZER PROD INC (US) 2005-02-02 CN disclosed
US-5821241-A INHIBIT BINDING OF FIBRINOGEN TO BLOOD PLATELETS, INHIBIT AGGREGATION OF BLOOD PLATELETS, PREVENT OR TREAT THROMBUS OR EMBOLUS FORMATION MERCK & CO., INC. (US) 1998-10-13 US disclosed
EP-0684823-A4 FIBRINOGEN RECEPTOR ANTAGONISTS. MERCK & CO INC (US) 1997-07-09 EP disclosed
EP-0684823-A1 FIBRINOGEN RECEPTOR ANTAGONISTS MERCK & CO. INC. (US) 1995-12-06 EP disclosed
WO-1994018981-A1 FIBRINOGEN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1994-09-01 WO disclosed